Recent Posts in September, 2011

• FDA Warns Against Taking Celexa in High Doses

  Sep 15, 2011
  In August 2011, the U.S. Food and Drug Administration (FDA) issued a warning that the antidepressant Celexa may cause a potentially fatal heart ...
  Posted By Rheingold, Valet, Rheingold, Ruffo & Giuffra LLP
  Continue Reading

• FDA Fosamax Panel Could be Full of Conflicts of Interest

  Sep 9, 2011
  The upcoming FDA panel evaluating the risks associated with long term bisphosphonate use could be rittled with conflicts of interest Pharmalot ...
  Posted By Rheingold, Valet, Rheingold, Ruffo & Giuffra LLP
  Continue Reading

• Stillbirth Malpractice Suits Make Headway in New York

  Sep 8, 2011
  According to the New York Times article in August 2011, two stillbirth malpractice suits in New York made legal headway by prompting state courts to ...
  Posted By Rheingold, Valet, Rheingold, Ruffo & Giuffra LLP
  Continue Reading

• Post Mensing Generic Litigation

  Sep 6, 2011
  A legal decision in the world of post Mensing generic pharmaceutical litigation could be a glimmer of hope for those who have suffered side effects ...
  Posted By Rheingold, Valet, Rheingold, Ruffo & Giuffra LLP
  Continue Reading

• Federal Registry Set Up for Silicone Breast Implant Users

  Sep 2, 2011
  Women who have gotten silicone implants in the past decade are now being encouraged by a federal advisory board to follow up on their implant ...
  Posted By Rheingold, Valet, Rheingold, Ruffo & Giuffra LLP
  Continue Reading